tiprankstipranks
MapLight Therapeutics, Inc. (MPLT)
NASDAQ:MPLT
US Market
MPLT
MapLight Therapeutics, Inc.
RESEARCH TOOLSreports

MapLight Therapeutics, Inc. (MPLT) Financial Statements

Compare
10 Followers

MapLight Therapeutics, Inc. Financial Overview

MapLight Therapeutics, Inc.'s market cap is currently $787.19M. The company's EPS TTM is $; its P/E ratio is -4.80; MapLight Therapeutics, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -578.00K$ -701.00K$ -556.00K$ -574.00K
Operating Income$ -169.08M$ -82.95M$ -57.28M$ -31.25M
EBITDA$ -168.50M$ -76.88M$ -55.15M$ -29.44M
Net Income$ -161.15M$ -77.58M$ -55.71M$ -30.02M
Balance Sheet
Cash & Short-Term Investments$ 305.10M$ 108.80M$ 79.77M$ 27.66M
Total Assets$ 479.51M$ 136.92M$ 91.41M$ 39.39M
Total Debt$ 5.80M$ 6.58M$ 5.92M$ 6.27M
Net Debt$ -40.93M$ -31.67M$ -73.84M$ -21.39M
Total Liabilities$ 21.14M$ 21.72M$ 20.13M$ 18.52M
Stockholders' Equity$ 458.37M$ 115.19M$ 71.28M$ 20.87M
Cash Flow
Free Cash Flow$ -138.61M$ -79.58M$ -52.47M$ -27.32M
Operating Cash Flow$ -138.14M$ -78.81M$ -52.01M$ -26.58M
Investing Cash Flow$ -323.21M$ -80.79M$ -462.00K$ -746.00K
Financing Cash Flow$ 469.82M$ 118.06M$ 104.57M$ 33.17M
Currency in USD

MapLight Therapeutics, Inc. Earnings and Revenue History

Income Statement >

MapLight Therapeutics, Inc. Debt to Assets

Balance Sheet >

MapLight Therapeutics, Inc. Cash Flow

Cash Flow >

MapLight Therapeutics, Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >